A Greek company specialized in the field of biomedical engineering is offering two innovative portable systems for in-vivo imaging of radiolabeled biomolecules and nanoparticles.

Both public and private partners, of any size, active in the market of molecular imaging are sought with an interest in establishing a commercial agreement with technical assistance or joint venture agreement.

Greek SME with significant research and professional experience in the field of biomedical engineering and mainly in the emerging molecular imaging technology has developed two novel systems for in-vivo molecular imaging.

Molecular imaging is now a standard, efficient tool in clinical and mainly preclinical research for the study of new drugs, biomolecules and nanoparticles. Based on that, the Greek company is focused in the use of radioisotopes to label and image those molecules. Although multimodal imaging systems exist, their purchase and maintenance cost is non affordable to the majority of small and medium research groups. To this direction, they are developing low cost, benchtop imaging systems, which can be easily acquired by any research team working in the field of biotechnology and medical research worldwide.

Currently, two systems are provided which cover the complementary techniques of SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) isotopes. Both systems are benchtop and can fill in the gap between ex-vivo biodistributions and advanced imaging systems. They have a 5×10 cm² field of view, allowing whole-body mice studies and they support static and fast dynamic whole-body imaging. Their size is comparable to a small printer and they can transform a lab desk into an in vivo imaging laboratory. Their small size and weight allow easy transport to other labs for providing imaging services.

Read more…